Cargando…

β-Asarone increases doxorubicin sensitivity by suppressing NF-κB signaling and abolishes doxorubicin-induced enrichment of stem-like population by destabilizing Bmi1

BACKGROUND: Lymphoma is one of the most common hematologic malignancy. Drug resistance is the main obstacle faced in lymphoma treatment. Cancer stem cells are considered as the source of tumor recurrence, metastasis and drug resistance. The β-Asarone, a low-toxicity compound from the traditional med...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lv, Li-Na, Wang, Xiao-Chao, Tao, Li-Ju, Li, Hong-Wen, Li, Shu-You, Zheng, Fei-Meng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6547485/ https://www.ncbi.nlm.nih.gov/pubmed/31171917 http://dx.doi.org/10.1186/s12935-019-0873-3

Ejemplares similares

ACOX1 destabilizes p73 to suppress intrinsic apoptosis pathway and regulates sensitivity to doxorubicin in lymphoma cells
por: Zheng, Fei-Meng, et al.
Publicado: (2019)

Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss
por: Ortiz-Lazareno, Pablo César, et al.
Publicado: (2014)

Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals
por: Osman, Abdel-Moneim M, et al.
Publicado: (2013)

Sulbactam-enhanced cytotoxicity of doxorubicin in breast cancer cells
por: Wen, Shao-hsuan, et al.
Publicado: (2018)

Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
por: Xu, Feifei, et al.
Publicado: (2014)

3D collagen type I matrix inhibits the antimigratory effect of doxorubicin
por: Millerot-Serrurot, Emilie, et al.
Publicado: (2010)

Modulation of doxorubicin cytotoxicity by resveratrol in a human breast cancer cell line
por: Osman, Abdel-Moneim M, et al.
Publicado: (2012)

NAP1L1 is a prognostic biomarker and contribute to doxorubicin chemotherapy resistance in human hepatocellular carcinoma
por: Le, Yong, et al.
Publicado: (2019)

Synergistic effects of isomorellin and forbesione with doxorubicin on apoptosis induction in human cholangiocarcinoma cell lines
por: Hahnvajanawong, Chariya, et al.
Publicado: (2014)

Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?
por: Zhang, Xudong, et al.
Publicado: (2018)

Attenuation of doxorubicin-induced cardiotoxicity by esculetin through modulation of Bmi-1 expression
por: Xu, Fan, et al.
Publicado: (2017)

Secretory leukocyte protease inhibitor suppresses HPV E6-expressing HNSCC progression by mediating NF-κB and Akt pathways
por: Jin, Yu, et al.
Publicado: (2019)

CircRNA-CREIT inhibits stress granule assembly and overcomes doxorubicin resistance in TNBC by destabilizing PKR
por: Wang, Xiaolong, et al.
Publicado: (2022)

Circular RNA circCSPP1 knockdown attenuates doxorubicin resistance and suppresses tumor progression of colorectal cancer via miR-944/FZD7 axis
por: Xi, Lanlan, et al.
Publicado: (2021)

Knockdown of PLC-gamma-2 and calmodulin 1 genes sensitizes human cervical adenocarcinoma cells to doxorubicin and paclitaxel
por: Stanislaus, Anthony, et al.
Publicado: (2012)

Self-assembling chimeric polypeptide-doxorubicin conjugate nanoparticles that abolish tumors after a single injection
por: MacKay, J. Andrew, et al.
Publicado: (2009)

Circ_0001721 enhances doxorubicin resistance and promotes tumorigenesis in osteosarcoma through miR-758/TCF4 axis
por: Guan, Huapeng, et al.
Publicado: (2021)

TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination
por: Jiang, Cheng-Fei, et al.
Publicado: (2021)

β-catenin promotes MTX resistance of leukemia cells by down-regulating FPGS expression via NF-κB
por: Liu, Shu-Guang, et al.
Publicado: (2020)

Modulation of doxorubicin-induced expression of the multidrug resistance gene in breast cancer cells by diltiazem and protection against cardiotoxicity in experimental animals
por: Al-malky, Hamdan S., et al.
Publicado: (2019)

RNA helicase DHX15 decreases cell apoptosis by NF-κB signaling pathway in Burkitt lymphoma
por: Chen, Yuan, et al.
Publicado: (2022)

Cathepsin B aggravated doxorubicin-induced myocardial injury via NF-κB signalling
por: Liu, Chen, et al.
Publicado: (2020)

Changes in the MALT1-A20-NF-κB expression pattern may be related to T cell dysfunction in AML
por: Shi, Li, et al.
Publicado: (2013)

Promotion of gastric tumor initiating cells in a 3D collagen gel culture model via YBX1/SPP1/NF-κB signaling
por: Deng, Shuangya, et al.
Publicado: (2021)

Phenyllactic acid promotes cell migration and invasion in cervical cancer via IKK/NF-κB-mediated MMP-9 activation
por: Li, Chao, et al.
Publicado: (2019)

Overexpression of MALT1-A20-NF-κB in adult B-cell acute lymphoblastic leukemia
por: Xu, Yi, et al.
Publicado: (2015)

Shengxian decoction decreases doxorubicin-induced cardiac apoptosis by regulating the TREM1/NF-κB signaling pathway
por: Yao, Lei, et al.
Publicado: (2021)

Addressing Reported Pro-Apoptotic Functions of NF-κB: Targeted Inhibition of Canonical NF-κB Enhances the Apoptotic Effects of Doxorubicin
por: Bednarski, Brian K., et al.
Publicado: (2009)

TFEB-NF-κB inflammatory signaling axis: a novel therapeutic pathway of Dihydrotanshinone I in doxorubicin-induced cardiotoxicity
por: Wang, Xiaoping, et al.
Publicado: (2020)

Celastrol induces apoptosis of gastric cancer cells by miR-146a inhibition of NF-κB activity
por: Sha, Min, et al.
Publicado: (2013)

Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
por: Porciani, David, et al.
Publicado: (2015)

Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway
por: Liu, Xuejiao, et al.
Publicado: (2020)

Blockade of L-type Ca(2+) channel attenuates doxorubicin-induced cardiomyopathy via suppression of CaMKII-NF-κB pathway
por: Ikeda, Soichiro, et al.
Publicado: (2019)

I-κB kinase-ε deficiency improves doxorubicin-induced dilated cardiomyopathy by inhibiting the NF-κB pathway
por: Liu, Yafeng, et al.
Publicado: (2022)

Local penetration of doxorubicin via intrahepatic implantation of PLGA based doxorubicin-loaded implants
por: Gao, Li, et al.
Publicado: (2019)

Basigin-2 upregulated by receptor activator of NF-κB ligand enhances lung cancer-induced osteolytic lesions
por: Liao, Cheng-Gong, et al.
Publicado: (2016)

Upregulation of NPL4 promotes bladder cancer cell proliferation by inhibiting DXO destabilization of cyclin D1 mRNA
por: Lu, Bao-Sai, et al.
Publicado: (2019)

Circ_ZNF124 promotes non-small cell lung cancer progression by abolishing miR-337-3p mediated downregulation of JAK2/STAT3 signaling pathway
por: Li, Qianping, et al.
Publicado: (2019)

Deposition of Doxorubicin in Rats following Administration of Three Newly Synthesized Doxorubicin Conjugates
por: Huan, Menglei, et al.
Publicado: (2013)

A novel phosphoramide compound, DCZ0805, shows potent anti-myeloma activity via the NF-κB pathway
por: Gao, Xuejie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5o5u6qoqjt6m8tpppemjbbpkuq